Abstract
Heterologous natural product biosynthesis has emerged as a strategy to produce medicinal compounds that pose challenges to conventional production routes. Polyketide compounds, an important class of natural products with wide-ranging therapeutic value, have been heterologously produced through Escherichia coli, presenting new opportunities to realize the medicinal potential of polyketide natural products. However, current production levels are often suboptimal when compared to native strain producers or heterologous theoretical yields. This problem provides an excellent opportunity to apply and further develop current metabolic engineering tools.
Similar content being viewed by others
References
Alper H, Stephanopoulos G (2007) Global transcription machinery engineering: a new approach for improving cellular phenotype. Metab Eng 9:258–267
Alper H, Fischer C, Nevoigt E et al (2005) Tuning genetic control through promoter engineering. Proc Natl Acad Sci USA 102:12678–12683
Alper H, Moxley J, Nevoigt E et al (2006) Engineering yeast transcription machinery for improved ethanol tolerance and production. Science 314:1565–1568
Bailey JE (1991) Toward a science of metabolic engineering. Science 252:1668–1675
Borodina I, Krabben P, Nielsen J (2005) Genome-scale analysis of Streptomyces coelicolor A3(2) metabolism. Genome Res 15:820–829
Camilli A, Bassler BL (2006) Bacterial small-molecule signaling pathways. Science 311:1113–1116
Cane DE, Walsh CT, Khosla C (1998) Harnessing the biosynthetic code: combinations, permutations, and mutations. Science 282:63–68
Datsenko KA, Wanner BL (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 97:6640–6645
Duarte NC, Herrgard MJ, Palsson BØ (2004) Reconstruction and validation of Saccharomyces cerevisiae iND750, a fully compartmentalized genome-scale metabolic model. Genome Res 14:1298–1309
Edwards JS, Ibarra RU, Palsson BØ (2001) In silico predictions of Escherichia coli metabolic capabilities are consistent with experimental data. Nat Biotechnol 19:125–130
Edwards JS, Covert M, Palsson B (2002) Metabolic modelling of microbes: the flux-balance approach. Environ Microbiol 4:133–140
Eppelmann K, Doekel S, Marahiel MA (2001) Engineered biosynthesis of the peptide antibiotic bacitracin in the surrogate host Bacillus subtilis. J Biol Chem 276:34824–34831
Feist AM, Henry CS, Reed JL et al (2007) A genome-scale metabolic reconstruction for Escherichia coli K-12 MG1655 that accounts for 1,260 ORFs and thermodynamic information. Mol Sys Biol 3:121
Fischbach MA, Walsh CT (2006) Assembly-line enzymology for polyketide and nonribosomal peptide antibiotics: logic, machinery, and mechanisms. Chem Rev 106:3468–3496
Fong R, Hu Z, Hutchinson CR et al (2007) Characterization of a large, stable, high-copy-number Streptomyces plasmid that requires stability and transfer functions for heterologous polyketide overproduction. Appl Environ Microbiol 73:1296–1307
González-Lergier J, Broadbelt LJ, Hatzimanikatis V (2006) Analysis of the maximum theoretical yield for the synthesis of erythromycin precursors in Escherichia coli. Biotechnol Bioeng 95:638–644
Kao CM, Katz L, Khosla C (1994) Engineered biosynthesis of a complete macrolactone in a heterologous host. Science 265:509–512
Kern A, Tilley E, Hunter IS et al (2007) Engineering primary metabolic pathways of industrial micro-organisms. J Biotechnol 129:6–29
Khosla C, Tang Y, Chen AY et al (2007) Structure and mechanism of the 6-deoxyerythronolide B synthase. Annu Rev Biochem 76:195–221
Koffas M, Stephanopoulos G (2005) Strain improvement by metabolic engineering: lysine production as a case study for systems biology. Curr Opin Biotechnol 16:361–366
Kunst F, Ogasawara N, Moszer I et al (1997) The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature 390:249–256
Lau J, Tran C, Licari P et al (2004) Development of a high cell-density fed-batch bioprocess for the heterologous production of 6-deoxyerythronolide B in Escherichia coli. J Biotechnol 110:95–103
Lee HY, Khosla C (2007) Bioassay-guided evolution of glycosylated macrolide antibiotics in Escherichia coli. PLoS Biol 5:e45
Minas W, Brunker P, Kallio PT et al (1998) Improved erythromycin production in a genetically engineered industrial strain of Saccharopolyspora erythraea. Biotechnol Prog 14:561–566
Mutka SC, Bondi SM, Carney JR et al (2006a) Metabolic pathway engineering for complex polyketide biosynthesis in Saccharomyces cerevisiae. FEMS Yeast Res 6:40–47
Mutka SC, Carney JR, Liu Y et al (2006b) Heterologous production of epothilone C and D in Escherichia coli. Biochemistry 45:1321–1330
Nielsen J (2003) It is all about metabolic fluxes. J Bacteriol 185:7031–7035
Nielsen J, Oliver S (2005) The next wave in metabolome analysis. Trends Biotechnol 23:544–546
Oh YK, Palsson BØ, Park SM et al (2007) Genome-scale reconstruction of metabolic network in Bacillus subtilis based on high-throughput phenotyping and gene essentiality data. J Biol Chem 282:28791–28799
Peirú S, Menzella HG, Rodríguez E et al (2005) Production of the potent antibacterial polyketide erythromycin C in Escherichia coli. Appl Environ Microbiol 71:2539–2547
Pfeifer BA, Khosla C (2001) Biosynthesis of polyketides in heterologous hosts. Microbiol Mol Biol Rev 65:106–118
Pfeifer BA, Admiraal SJ, Gramajo H et al (2001) Biosynthesis of complex polyketides in a metabolically engineered strain of E. coli. Science 291:1790–1792
Pfeifer B, Hu Z, Licari P et al (2002) Process and metabolic strategies for improved production of Escherichia coli-derived 6-deoxyerythronolide B. Appl Environ Microbiol 68:3287–3292
Pitera DJ, Paddon CJ, Newman JD et al (2007) Balancing a heterologous mevalonate pathway for improved isoprenoid production in Escherichia coli. Metab Eng 9:193–207
Price ND, Reed JL, Palsson BØ (2004) Genome-scale models of microbial cells: evaluating the consequences of constraints. Nat Rev Microbiol 2:886–897
Reed JL, Palsson BØ (2003) Thirteen years of building constraint-based in silico models of Escherichia coli. J Bacteriol 185:2692–2699
Schuetz R, Kuepfer L, Sauer U (2007) Systematic evaluation of objective functions for predicting intracellular fluxes in Escherichia coli. Mol Syst Biol 3:119
Schumann W (2007) Production of recombinant proteins in Bacillus subtilis. Adv Appl Microbiol 62:137–189
Spencer JF, Ragout de Spencer AL, Laluce C (2002) Non-conventional yeasts. Appl Microbiol Biotechnol 58:147–156
Stephanopoulos G (1999) Metabolic fluxes and metabolic engineering. Metab Eng 1:1–11
Suthers PF, Burgard AP, Dasika MS et al (2007) Metabolic flux elucidation for large-scale models using (13)C labeled isotopes. Metab Eng 9:387–405
Tyo KE, Alper HS, Stephanopoulos GN (2007) Expanding the metabolic engineering toolbox: more options to engineer cells. Trends Biotechnol 25:132–137
Vallino JJ, Stephanopoulos G (1993) Metabolic flux distributions in Corynebacterium glutamicum during growth and lysine overproduction. Biotechnol Bioeng 41:633–646
van der Werf MJ, Overkamp KM, Muilwijk B et al (2007) Microbial metabolomics: toward a platform with full metabolome coverage. Anal Biochem 370:17–25
Wang Y, Pfeifer BA (2008) 6-Deoxyerythronolide B production through chromosomal localization of the deoxyerythronolide B synthase genes in E. coli. Metab Eng 10:33–38
Wang Y, Boghigian BA, Pfeifer BA (2007a) Improving heterologous polyketide production in Escherichia coli by overexpression of an S-adenosylmethionine synthetase gene. Appl Microbiol Biotechnol 77:367–373
Wang Y, Wang Y, Chu J et al (2007b) Improved production of erythromycin A by expression of a heterologous gene encoding S-adenosylmethionine synthetase. Appl Microbiol Biotechnol 75:837–842
Watanabe K, Rude MA, Walsh CT et al (2003) Engineered biosynthesis of an ansamycin polyketide precursor in Escherichia coli. Proc Natl Acad Sci USA 100:9774–9778
Wenzel SC, Gross F, Zhang Y et al (2005) Heterologous expression of a myxobacterial natural products assembly line in pseudomonads via red/ET recombineering. Chem Biol 12:349–356
Zhang H, Wang Y, Pfeifer BA (2008) Bacterial hosts for natural product production. Mol Pharm (in press). doi:10.1021/mp7001329
Acknowledgements
BAB would like to thank Prof. Kyongbum Lee, Dr. Yong Wang, and Haoran Zhang for their continued insightful discussions. BAB would also like to thank the Tufts University BREEM Program (started through National Institutes of Health #R25 GM073177-01) and the Tufts Faculty Research Awards Committee for support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Boghigian, B.A., Pfeifer, B.A. Current status, strategies, and potential for the metabolic engineering of heterologous polyketides in Escherichia coli . Biotechnol Lett 30, 1323–1330 (2008). https://doi.org/10.1007/s10529-008-9689-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10529-008-9689-2